A pilot study to assess effects of long-term inhalation of airborne particulate matter on early Alzheimer-like changes in the mouse brain
- PMID: 25992783
- PMCID: PMC4439054
- DOI: 10.1371/journal.pone.0127102
A pilot study to assess effects of long-term inhalation of airborne particulate matter on early Alzheimer-like changes in the mouse brain
Abstract
Exposure to air pollutants, including particulate matter, results in activation of the brain inflammatory response and Alzheimer disease (AD)-like pathology in dogs and humans. However, the length of time required for inhalation of ambient particulate matter to influence brain inflammation and AD pathology is less clear. Here, we studied the effect of 3 and 9 months of air particulate matter (<2.5 μm diameter, PM2.5) exposure on brain inflammatory phenotype and pathological hallmarks of AD in C57BL/6 mice. Using western blot, ELISA, and cytokine array analysis we quantified brain APP, beta-site APP cleaving enzyme (BACE), oligomeric protein, total Aβ 1-40 and Aβ 1-42 levels, inducible nitric oxide synthase (iNOS), nitrotyrosine-modified proteins, HNE-Michael adducts, vascular cell adhesion molecule 1 (VCAM-1), glial markers (GFAP, Iba-1), pre- and post- synaptic markers (synaptophysin and PSD-95), cyclooxygenase (COX-1, COX-2) levels, and the cytokine profile in PM2.5 exposed and filtered air control mice. Only 9 month PM2.5 exposure increased BACE protein levels, APP processing, and Aβ 1-40 levels. This correlated with a concomitant increase in COX-1 and COX-2 protein levels and a modest alteration in the cytokine profile. These data support the hypothesis that prolonged exposure to airborne particulate matter has the potential to alter brain inflammatory phenotype and promote development of early AD-like pathology.
Conflict of interest statement
Figures











Similar articles
-
Inflammatory prostaglandin E2 signaling in a mouse model of Alzheimer disease.Ann Neurol. 2012 Nov;72(5):788-98. doi: 10.1002/ana.23677. Epub 2012 Aug 22. Ann Neurol. 2012. PMID: 22915243 Free PMC article.
-
Multitarget Therapeutic Effect of Fasudil in APP/PS1transgenic Mice.CNS Neurol Disord Drug Targets. 2017;16(2):199-209. doi: 10.2174/1871527315666160711104719. CNS Neurol Disord Drug Targets. 2017. PMID: 27401064
-
Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.Neurobiol Dis. 2016 Jan;85:187-205. doi: 10.1016/j.nbd.2015.11.005. Epub 2015 Nov 10. Neurobiol Dis. 2016. PMID: 26563932
-
Pediatric respiratory and systemic effects of chronic air pollution exposure: nose, lung, heart, and brain pathology.Toxicol Pathol. 2007 Jan;35(1):154-62. doi: 10.1080/01926230601059985. Toxicol Pathol. 2007. PMID: 17325984 Review.
-
Alzheimer's disease.Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Subcell Biochem. 2012. PMID: 23225010 Review.
Cited by
-
Cell-based assays that predict in vivo neurotoxicity of urban ambient nano-sized particulate matter.Free Radic Biol Med. 2019 Dec;145:33-41. doi: 10.1016/j.freeradbiomed.2019.09.016. Epub 2019 Sep 19. Free Radic Biol Med. 2019. PMID: 31542466 Free PMC article.
-
Effects of air pollution on the nervous system and its possible role in neurodevelopmental and neurodegenerative disorders.Pharmacol Ther. 2020 Jun;210:107523. doi: 10.1016/j.pharmthera.2020.107523. Epub 2020 Mar 9. Pharmacol Ther. 2020. PMID: 32165138 Free PMC article. Review.
-
NF-κB-regulated microRNA-574-5p underlies synaptic and cognitive impairment in response to atmospheric PM2.5 aspiration.Part Fibre Toxicol. 2017 Aug 29;14(1):34. doi: 10.1186/s12989-017-0215-3. Part Fibre Toxicol. 2017. PMID: 28851397 Free PMC article.
-
Alzheimer and depressive cognitive-like behaviors in male and female rats: A new method for exposure to ambient air pollution.MethodsX. 2019 Mar 28;6:690-703. doi: 10.1016/j.mex.2019.03.018. eCollection 2019. MethodsX. 2019. PMID: 31008063 Free PMC article.
-
Association Between Ambient Air Pollution and Amyloid Positron Emission Tomography Positivity in Older Adults With Cognitive Impairment.JAMA Neurol. 2021 Feb 1;78(2):197-207. doi: 10.1001/jamaneurol.2020.3962. JAMA Neurol. 2021. PMID: 33252608 Free PMC article.
References
-
- Maslow K, Maslow K, Alzheimer's A 2010 Alzheimer's disease facts and figures. Alzheimer's & dementia: the journal of the Alzheimer's Association. 2010;6: 158–94. - PubMed
-
- Thies W, Bleiler L, Alzheimer's A 2013 Alzheimer's disease facts and figures. Alzheimer's & dementia: the journal of the Alzheimer's Association. 2013;9: 208–45. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous